GAL-021

GAL-021

Clinical data
Routes of administration	IV
ATC code	None
Legal status
Legal status	US: Investigational New Drug
Identifiers
IUPAC name 2-[(N-Methyl-N-methoxy)amino]-4,6-bis(propylamino)-1,3,5-triazine
CAS Number	1380341-99-0
PubChem CID	57340959
UNII	4RZ4OGT40Z
Chemical and physical data
Formula	C11H22N6O
Molar mass	254.338 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCNc1nc(nc(N(C)OC)n1)NCCC

GAL-021 is a drug related to almitrine which acts as a respiratory stimulant, with its mechanism of action primarily thought to involve blocking the BK_Ca potassium channel, although secondary mechanisms may also be involved. It was developed by Galleon Pharmaceuticals, and is being tested in clinical trials for potential uses in post-operative care, as well as more generally to counteract the respiratory depression which can be a side effect of opioid analgesic drugs.

See also

• BIMU8
• CX717